
-
ESSA Pharma NasdaqCM:EPIX ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company was incorporated in 2009 and is headquartered in Vancouver, Canada.
Location: 999 West Broadway, Vancouver, BC, V5Z 1K5, Canada | Website: https://www.essapharma.com | Industry: Biotechnology | Sector: Healthcare
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-39.46M
Cash
113.9M
Avg Qtr Burn
-5.607M
Short % of Float
2.47%
Insider Ownership
6.02%
Institutional Own.
69.42%
Qtr Updated
03/31/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Masofaniten (EPI-7386) (antiandrogen) + apalutamide and abiraterone acetate Details Cancer, Prostate cancer | Failed Discontinued | |
Masofaniten (EPI-7386) (antiandrogen) combo w/ enzalutamide Details Prostate cancer, Cancer | Failed Discontinued | |
Masofaniten (EPI-7386) (antiandrogen) Monotherapy Details Castration-resistant prostate cancer | Failed Discontinued |